Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
10/19Moderna CEO Expects Covid-19 Vaccine Interim Results in November
DJ
10/19Moderna CEO Expects Covid-19 Vaccine Interim Results in November
DJ
10/19JIANGSU HENGRUI MEDICINE : Nine-Month Net Profit Rose 14%
DJ
10/19Bayer's Orbia plans Latam expansion after Bunge deal in Brazil
RE
10/19Philips growth spurred by COVID-19 demand and distant care
RE
10/19France's Ose to enrol up to 400 for 'T-cell' coronavirus vaccine trials
RE
10/19France's Ose to enroll up to 400 for 'T-cell' coronavirus vaccine trials
RE
10/19China's Sinovac vaccine is safe, Brazil institute says
RE
10/19Brazil's Butantan says tests show vaccine by China's Sinovac is safe
RE
10/19ABBVIE : Seeks U.S., European OK of Rinvoq in Eczema
DJ
10/19BAYER AG : UBS keeps its Buy rating
MD
10/19ASTRAZENECA : Receives a Sell rating from Goldman Sachs
MD
10/19GERRESHEIMER AG : Gets a Sell rating from DZ Bank
MD
10/19ELI LILLY : Health Canada Approves Taltz for Non-Radiographic Axial Spondyloarthritis
DJ
10/19CVS HEALTH : to Hire 15,000 Employees in the U.S. in 4Q
DJ
Discover
10/19PHILIPS NV : Goldman Sachs remains its Buy rating
MD
10/19PHILIPS NV : Kepler Cheuvreux gives a Neutral rating
MD
10/19DRAEGERWERK : Independant Research gives a Neutral rating
MD
10/19BRISTOL MYERS SQUIBB : Exelixis Get Priority Review for Kidney-Cancer Treatment
DJ
10/19LabCorp launches test to measure COVID-19 antibodies in clinical trials
RE
10/19FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Warburg Research gives a Neutral rating
MD
10/19ROCHE HOLDINGS AG : JP Morgan reaffirms its Buy rating
MD
10/19KONINKLIJKE PHILIPS N : Philips 3Q Net Profit Rose as Sales Returned to Growth -- Update
DJ
10/19DERMAPHARM : Berenberg reiterates its Buy rating
MD
10/19PHILIPS NV : Bernstein reiterates its Buy rating
MD
10/19PHILIPS NV : JP Morgan reaffirms its Neutral rating
MD
10/19EVOTEC : Baader Bank keeps its Buy rating
MD
10/19SANOFI : Gets a Buy rating from Goldman Sachs
MD
10/19SHIELD THERAPEUTICS : Peer Teva Pharmaceutical Industries Withdraws Oppositions to Patents
DJ
10/19EVOTEC : secures grant to evaluate antibody drugs for COVID-19
RE
10/19ASTRAZENECA : wins two approval recommendations from EU agency
RE
10/19KONINKLIJKE PHILIPS N : Philips 3Q Net Profit Rose; Targets Higher Profitability for 2021-2025
DJ
10/18SHANGHAI JUNSHI BIOSCIENCES : May Benefit From Covid-19 Neutralising Antibody
DJ
10/18SERUM INSTITUTE, BHARAT BIOTECH TO BEGIN TRIAL OF INTRANASAL COVID-19 VACCINE SOON : Vardhan
RE
10/17TOP GLOVE BHD : Malaysia has inspected, will monitor rubber manufacturers' labour law compliance
RE
10/17DR REDDY LABORATORIES : Russia receives renewed approval for COVID-19 vaccine trials in India -RDIF
RE
10/16Pfizer says earliest U.S. filing for COVID-19 vaccine would be late November
RE
10/16GILEAD SCIENCES : WHO-Backed Study Finds No Remdesivir Benefit for Hospitalized Covid-19 Patients -- Update
DJ
10/16GILEAD SCIENCES : FDA Says Remdesivir EUA Letter Of Authorization, Reissued Oct 16
RE
10/16Confirmed Coronavirus Cases in U.S. Surpass 8 Million -- 4th Update
DJ
10/16Confirmed Coronavirus Cases in U.S. Surpass 8 Million -- 4th Update
DJ
10/16GILEAD SCIENCES : WHO-Backed Study Finds No Remdesivir Benefit for Hospitalized Covid-19 Patients
DJ
10/16CVS HEALTH : Preparing to Provide Covid Vaccine to Long-Term Care Facilities When Available
DJ
10/16PFIZER INC : RBC reiterates its Buy rating
MD
10/16NOVO NORDISK : Buy rating from Goldman Sachs
MD
10/16CVS HEALTH : Walgreens to Get Government Vaccine Deal for Long-Term Care Facilities -Politico
DJ
10/16EXPLAINER : When will COVID-19 vaccines be generally available in the United States?
RE
10/16GILEAD SCIENCES : EU urged to review remdesivir supply deal after COVID-19 trial results
RE
10/16Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November -- Update
DJ
10/16REGENERON PHARMACEUTICALS : Sanofi Get CHMP Backing for Dupixent in Children With Severe Atopic Dermatitis
DJ
10/16JOHNSON & JOHNSON : J&J's Janssen Gets CHMP Positive Opinion for Tremfya in Active Psoriatic Arthritis
DJ
10/16GILEAD SCIENCES : Kite Says CHMP Adopts Positive Opinion for Lymphoma Drug
DJ
10/16BRISTOL MYERS SQUIBB : Gets Positive CHMP Opinion for Opdivo in Esophageal Cancer
DJ
10/16NIH to Study Three Drugs in Treatment of Covid-19 Patients
DJ
10/16Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November -- 2nd Update
DJ
10/16Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November -- Update
DJ
10/16Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November -- Update
DJ
10/16ANALYSIS : Sales of first big COVID-19 drug, remdesivir, may disappoint
RE
10/16Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November
DJ
10/16ROCHE HOLDINGS AG : UBS keeps its Buy rating
MD
10/16Physiomics Wins Contracts With Existing Customers
DJ
10/16ROCHE HOLDINGS AG : Bernstein maintains a Buy rating
MD
10/16DRAEGERWERK : Buy rating from Hauck & Aufhauser
MD
10/16ROCHE HOLDINGS AG : Credit Suisse remains Neutral
MD
10/15GILEAD SCIENCES : Issues Statement On Solidarity Trial
RE
Discover
10/15GILEAD SCIENCES : WHO Says Solidarity Therapeutics Trial Produces Conclusive Evidence On Effectiveness Of Repurposed Drugs For COVID-19 In Record Time
RE
10/15Gilead questions WHO study that cast doubts on drug's COVID-19 benefits
RE
10/15GALAPAGOS : Servier Knee Osteoarthritis Trial Fails to Meet Primary, Secondary Endpoints
DJ
10/15INTUITIVE SURGICAL : Reports Lower 3Q Profit, Revenue Amid Pandemic -- Earnings Review
DJ
10/15PFIZER : BioNTech Race to Meet Global Covid-19 Vaccine Needs
DJ
1  2  3  4  5  6  7  8  9  10Next